A citation-based method for searching scientific literature

Jane S Paulsen, Jeffrey D Long, Hans J Johnson, Elizabeth H Aylward, Christopher A Ross, Janet K Williams, Martha A Nance, Cheryl J Erwin, Holly J Westervelt, Deborah L Harrington, H Jeremy Bockholt, Ying Zhang, Elizabeth A McCusker, Edmond M Chiu, Peter K Panegyres. Front Aging Neurosci 2014
Times Cited: 138







List of co-cited articles
661 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
502
46


Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
554
43

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
549
43

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill,[...]. Lancet Neurol 2009
652
41

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
Jane S Paulsen, Jeffrey D Long, Christopher A Ross, Deborah L Harrington, Cheryl J Erwin, Janet K Williams, Holly James Westervelt, Hans J Johnson, Elizabeth H Aylward, Ying Zhang,[...]. Lancet Neurol 2014
148
36


Indexing disease progression at study entry with individuals at-risk for Huntington disease.
Ying Zhang, Jeffrey D Long, James A Mills, John H Warner, Wenjing Lu, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2011
148
28

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, Alexandra Durr, Blair Leavitt, Gail Owen, Rebecca Jones, Hans Johnson, David Craufurd, Stephen L Hicks,[...]. Lancet Neurol 2012
362
27

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Sarah J Tabrizi, Rachael I Scahill, Alexandra Durr, Raymund Ac Roos, Blair R Leavitt, Rebecca Jones, G Bernhard Landwehrmeyer, Nick C Fox, Hans Johnson, Stephen L Hicks,[...]. Lancet Neurol 2011
390
20

Preparing for preventive clinical trials: the Predict-HD study.
Jane S Paulsen, Michael Hayden, Julie C Stout, Douglas R Langbehn, Elizabeth Aylward, Christopher A Ross, Mark Guttman, Martha Nance, Karl Kieburtz, David Oakes,[...]. Arch Neurol 2006
235
20

CAG repeat number governs the development rate of pathology in Huntington's disease.
J B Penney, J P Vonsattel, M E MacDonald, J F Gusella, R H Myers. Ann Neurol 1997
486
20

Diagnostic criteria for Huntington's disease based on natural history.
Ralf Reilmann, Blair R Leavitt, Christopher A Ross. Mov Disord 2014
106
20

Striatal and white matter predictors of estimated diagnosis for Huntington disease.
Jane S Paulsen, Peggy C Nopoulos, Elizabeth Aylward, Christopher A Ross, Hans Johnson, Vincent A Magnotta, Andrew Juhl, Ronald K Pierson, James Mills, Douglas Langbehn,[...]. Brain Res Bull 2010
170
15

Huntington's disease.
Francis O Walker. Lancet 2007
14


Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
615
13

Onset and rate of striatal atrophy in preclinical Huntington disease.
E H Aylward, B F Sparks, K M Field, V Yallapragada, B D Shpritz, A Rosenblatt, J Brandt, L M Gourley, K Liang, H Zhou,[...]. Neurology 2004
287
13

Cognitive decline in prodromal Huntington Disease: implications for clinical trials.
Jane S Paulsen, Megan M Smith, Jeffrey D Long. J Neurol Neurosurg Psychiatry 2013
67
17

Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease.
Georg B Landwehrmeyer, Cheryl J Fitzer-Attas, Joseph D Giuliano, Nilza Gonçalves, Karen E Anderson, Francisco Cardoso, Joaquim J Ferreira, Tiago A Mestre, Julie C Stout, Cristina Sampaio. Mov Disord Clin Pract 2016
94
12

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
12

Neurocognitive signs in prodromal Huntington disease.
Julie C Stout, Jane S Paulsen, Sarah Queller, Andrea C Solomon, Kathryn B Whitlock, J Colin Campbell, Noelle Carlozzi, Kevin Duff, Leigh J Beglinger, Douglas R Langbehn,[...]. Neuropsychology 2011
253
11

Cerebral cortex structure in prodromal Huntington disease.
Peggy C Nopoulos, Elizabeth H Aylward, Christopher A Ross, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Ronald K Pierson, James Mills, Douglas R Langbehn, Jane S Paulsen. Neurobiol Dis 2010
97
11



A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
D R Langbehn, R R Brinkman, D Falush, J S Paulsen, M R Hayden. Clin Genet 2004
539
11

Longitudinal change in regional brain volumes in prodromal Huntington disease.
Elizabeth H Aylward, Peggy C Nopoulos, Christopher A Ross, Douglas R Langbehn, Ronald K Pierson, James A Mills, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Jane S Paulsen. J Neurol Neurosurg Psychiatry 2011
175
11

Huntington disease: clinical care and evaluation.
I Shoulson, S Fahn. Neurology 1979
567
11

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.
H Diana Rosas, David H Salat, Stephanie Y Lee, Alexandra K Zaleta, Vasanth Pappu, Bruce Fischl, Doug Greve, Nathanael Hevelone, Steven M Hersch. Brain 2008
325
11


Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
933
10

Behavioral changes in Huntington Disease.
D Craufurd, J C Thompson, J S Snowden. Neuropsychiatry Neuropsychol Behav Neurol 2001
282
10

Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.
Kevin Duff, Jane S Paulsen, Leigh J Beglinger, Douglas R Langbehn, Julie C Stout. Biol Psychiatry 2007
269
10

Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data.
Eric A Epping, Ji-In Kim, David Craufurd, Thomas M Brashers-Krug, Karen E Anderson, Elizabeth McCusker, Jolene Luther, Jeffrey D Long, Jane S Paulsen. Am J Psychiatry 2016
65
15

Brain structure in preclinical Huntington's disease.
Jane S Paulsen, Vince A Magnotta, Ania E Mikos, Henry L Paulson, Elizabeth Penziner, Nancy C Andreasen, Peg C Nopoulos. Biol Psychiatry 2006
177
10

Validation of a prognostic index for Huntington's disease.
Jeffrey D Long, Douglas R Langbehn, Sarah J Tabrizi, Bernhard G Landwehrmeyer, Jane S Paulsen, John Warner, Cristina Sampaio. Mov Disord 2017
26
38

Huntington's disease: a clinical review.
Raymund A C Roos. Orphanet J Rare Dis 2010
441
9

Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.
Rachael I Scahill, Nicola Z Hobbs, Miranda J Say, Natalie Bechtel, Susie M D Henley, Harpreet Hyare, Douglas R Langbehn, Rebecca Jones, Blair R Leavitt, Raymund A C Roos,[...]. Hum Brain Mapp 2013
76
11

Striatal volume contributes to the prediction of onset of Huntington disease in incident cases.
Elizabeth H Aylward, Dawei Liu, Peggy C Nopoulos, Christopher A Ross, Ronald K Pierson, James A Mills, Jeffrey D Long, Jane S Paulsen. Biol Psychiatry 2012
83
10

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.
H D Rosas, N D Hevelone, A K Zaleta, D N Greve, D H Salat, B Fischl. Neurology 2005
232
9

Refining the diagnosis of Huntington disease: the PREDICT-HD study.
Kevin M Biglan, Ying Zhang, Jeffrey D Long, Michael Geschwind, Gail A Kang, Annie Killoran, Wenjing Lu, Elizabeth McCusker, James A Mills, Lynn A Raymond,[...]. Front Aging Neurosci 2013
57
15

Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
Simon J A van den Bogaard, Eve M Dumas, Tanka P Acharya, Hans Johnson, Douglas R Langbehn, Rachael I Scahill, Sarah J Tabrizi, Mark A van Buchem, Jeroen van der Grond, Raymund A C Roos. J Neurol 2011
87
10

The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis.
Tamara Pringsheim, Katie Wiltshire, Lundy Day, Jonathan Dykeman, Thomas Steeves, Nathalie Jette. Mov Disord 2012
286
9

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Lauren M Byrne, Filipe B Rodrigues, Kaj Blennow, Alexandra Durr, Blair R Leavitt, Raymund A C Roos, Rachael I Scahill, Sarah J Tabrizi, Henrik Zetterberg, Douglas Langbehn,[...]. Lancet Neurol 2017
170
9

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.
Scott A Schobel, Giuseppe Palermo, Peggy Auinger, Jeffrey D Long, Shiyang Ma, Omar S Khwaja, Dylan Trundell, Merit Cudkowicz, Steven Hersch, Cristina Sampaio,[...]. Neurology 2017
52
17

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
Kevin Michael Biglan, Ira Shoulson, Karl Kieburtz, David Oakes, Elise Kayson, M Aileen Shinaman, Hongwei Zhao, Megan Romer, Anne Young, Steven Hersch,[...]. JAMA Neurol 2016
32
28

Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Juan F Domínguez D, Gary F Egan, Marcus A Gray, Govinda R Poudel, Andrew Churchyard, Phyllis Chua, Julie C Stout, Nellie Georgiou-Karistianis. PLoS One 2013
60
13

Clinical markers of early disease in persons near onset of Huntington's disease.
J S Paulsen, H Zhao, J C Stout, R R Brinkman, M Guttman, C A Ross, P Como, C Manning, M R Hayden, I Shoulson. Neurology 2001
159
8

CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.
Douglas R Langbehn, Michael R Hayden, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2010
213
8

Tracking motor impairments in the progression of Huntington's disease.
Jeffery D Long, Jane S Paulsen, Karen Marder, Ying Zhang, Ji-In Kim, James A Mills. Mov Disord 2014
38
21


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.